Novavax’s updated protein-based COVID-19 vaccine now option for all 194 WHO member states
On Nov. 28, 2023, Novavax announced that Nuvaxovid XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) had been granted Emergency Use Listing…
-
-
Biotechnology | Clinical Research | COVID-19 | FDA | Infectious Disease | Medicine | NIH | Therapeutics | Vaccine
FDA issued final guidance on developing drugs for COVID-19 treatment and preventionﾠ
On Nov. 22, 2023, the U.S. Food and Drug Administration (FDA) issued the final guidance COVID-19: Developing Drugs…
-
Novavax’s updated COVID-19 vaccine approved in the EU
On Oct. 31, 2023, Novavax announced that the European Commission had granted approval for Nuvaxovid XBB.1.5 dispersion for…
-
Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
-
Novavax’s prototype COVID-19 vaccine Nuvaxovid received full approval in Singapore
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) had granted full approval for Novavax’s…
-
FDA authorized updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variant
On Oct. 3, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
-
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | Vaccine
Novavax 2023-2024 COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Oct. 3, 2023, Novavax announced that it’s COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) had received Emergency Use…
-
CDC | COVID-19 | Diagnostics | Infectious Disease | Oncology | Radiology
New cancer diagnoses fell abruptly early in the COVID-19 pandemic according to Annual Report to the Nation
On Sept. 27, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that new diagnoses of…
-
Biotechnology | Disease | Medicine | NIH | Therapeutics
NIH awarded $50.3 million for ‘multi-omics’ research on human health and disease
On Sept. 12, 2023, the National Institutes of Health announced it was establishing the Multi-Omics for Health and…
-
Biotechnology | Disease | NIH
NIH investigated multidrug-resistant bacterium emerging in community settings
On Sept. 6, 2023, the National Institutes of Health (NIH) announced it was investgating ‘hypervirulent’ strains of the…
-
Emergents’ NARCAN Nasal Spray launched OTC making it possible for everyone to help save a life from an opioid overdose Emergency
On Aug. 30, 2023, Emergent BioSolutions announced NARCAN® Naloxone HCl Nasal Spray 4 mg will be available on shelves…
-
CTE identified in brain donations from young amateur athletes
On Aug. 28, 2023, in a study of 152 deceased athletes less than 30 years old who were…
-
U.S. FDA approved first biosimilar to treat Multiple Sclerosis
On Aug. 24, 2023, the U.S. Food and Drug Administration (FDA) approved Sandoz’s Tyruko (natalizumab-sztn), the first biosimilar…
-
NIAID-funded study traced evolution of Malaria drug resistance in East Africa
On Aug. 24, 2023, the National Institute of Allergy and Infectious Diseases (NIAID) reported that emerging resistance to…
-
Maryland Department of Health announced positive case of locally acquired malaria
On Aug. 18, 2023, the Maryland Department of Health has confirmed and reported a positive case of locally…
-
National Institutes of Health established Maternal Health Research Centers of Excellence
On Aug. 17, 2023, the National Institutes of Health announced it had awarded $24 million in first-year funding…
-
NIH unveiled comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries
On Aug. 14, 2023, the National Institute of Health announced that it had released a comprehensive dataset that…
-
COVID-19 vaccination and boosting during pregnancy benefits pregnant women and newborns
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
-
Henrietta Lacks’ family settled lawsuit with biotech company that used her cells without consent
On Aug. 1, 2023, more than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical…
-
U.S. Department of Health and Human Services announced the Formation of the Office of Long COVID Research
On Jul. 31, 2023, the U.S. Department of Health and Human Services announced the formation of the Office…
-
Emergent BioSolutions awarded 10-Year BARDA contract valued at $704 million for Ebanga treatment for Ebola
On Jul. 31, 2023, Emergent BioSolutions announced that it was awarded a 10-year contract by the Biomedical Advanced…
-
U.S. FDA approved Ervebo first U.S.-licensed vaccine for prevention of Ebola virus disease
On Dec. 20, 2019, Merck announced that the U.S. Food and Drug Administration (FDA) had approved ERVEBO® (Ebola…
-
U.S. FDA approved second OTC Naloxone nasal spray product
On Jul. 28, 2023, the U.S. U.S. Food and Drug Administration (FDA) approved RiVive, 3 milligram (mg) naloxone…
-
Emergent BioSolutions received U.S. FDA approval of CYFENDUS Anthrax vaccine for post-exposure prophylaxis use
On Jul. 20, 2023, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had approved CYFENDUSﾙ…
-
NIH released new atlas of human kidney cells to help unlock kidney disease research
On Jul. 19, 2023, in a major breakthrough toward understanding and treating kidney disease, a nationwide research team…
-
U.S. FDA permitted marketing of first COVID-19 at-home test using traditional premarket review process
On Jun. 6, 2023, the U.S. Food and Drug Administration (FDA) granted granted marketing authorization for the Cue COVID-19…
-
NIAID Service IDs 3,000 natural products for disease-fighting potential
On Jun. 1, 2023, the National Institute of Allergy and Infectious Diseases and the National Cancer Institute reported…
-
Novavax’s Nuvaxovid received positive CHMP opinion for full marketing authorization for prevention of COVID in the EU
On May 26, 2023, Novavax announced that Nuvaxovid (NVX-CoV2373) had been recommended for full Marketing Authorization (MA) for…
-
Large study provided scientists with deeper insight into long COVID symptoms
On May 25, 2023, the National Institutes of Health (NIH) announced Initial findings from a study of nearly…
-
Biotechnology | Disease | Genomics | NIH | Non-Profit Research | Oncology | Therapeutics
NIH launched $140 million effort to investigate genetic variation in normal human cells and tissues
On May 11, 2023, the National Institutes of Health (NIH) announced launching a new program, the Common Fund’s…
